Charles River Laboratories (CRL)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 3,461,500 | 3,782,270 | 3,722,730 | 3,640,440 | 3,596,880 | 3,305,990 | 3,251,700 | 3,108,600 | 2,976,290 | 2,626,850 | 2,647,710 | 2,610,180 | 2,534,820 | 2,426,570 | 2,318,440 | 2,183,930 | 2,114,600 | 1,896,940 | 1,752,640 | 1,651,980 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $3,461,500K)
= 0.00
The debt-to-capital ratio of Charles River Laboratories has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations relative to its total capital over this time period. A debt-to-capital ratio of 0.00 suggests that the company relies more on equity financing for its operations, which may be viewed positively by investors and creditors as it implies lower financial risk and reduced interest expenses. Overall, the stable and low debt-to-capital ratio of Charles River Laboratories reflects a strong financial position and prudent capital structure management.
Peer comparison
Dec 31, 2024